Resource data sheet
Prev.
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pCAZ 2

E. coli LacZ genomic DNA

Catalog number RDB01870
Resource name pCAZ 2
Alternative name E. coli LacZ genomic DNA
Clone info. Expression vector of E. coli lacZ (no EcoR I site).
Vector backbone pCAGGS (Plasmid)
Size of vector backbone 4.7 kb
Selectable markers Amp^r (E. coli)
Gene/insert name E. coli lacZ (beta-D-galactosidase) Genomic DNA
Depositor|Developer Hamada, Hirofumi |
Other clones in our bank

External Database
E. coli lacZ (beta-D-galactosidase)

          Reference sequence
            

          Distribution information

          Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
          Terms and conditions set forth by the DEPOSITOR The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested.(Hum. Gene Ther., 9, 2503-2515 (1998).) In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
          Additional terms and conditions for distribution Regarding resources containing CAG promoter: In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation for the CAG promoter (Niwa, H., Yamamura, K., Miyazaki, J., Gene 108 : 193-200, 1991) and an acknowledgment to Dr. Jun-ich Miyazaki of the Osaka University are requested.
          Ordering Please visit Information of Request for Distribution.[link] 
          Order form 
          [Credit Card Payment]  [Bank Transfer Payment]
          Material Transfer Agreement (MTA for use for not-for-profit academic purpose) [Word]
          提供案内 (日本国内) [open/close]

          提供条件 非営利機関の非営利学術研究へ提供する。利用者が本件リソースを利用した研究成果に基づき特許申請、商業活動等を行う場合は、利用者は事前に寄託者に連絡する。利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する(Hum. Gene Ther., 9, 2503-2515 (1998).)。利用者は、研究成果の公表にあたって謝辞の表明を必要とする。
          付加的提供条件 CAGプロモータを含むリソースについて: 利用者は、研究成果の公表にあたってCAGプロモータの文献 (Niwa, H., Yamamura, K., Miyazaki, J., Gene 108 : 193-200, 1991)を引用し、大阪大学 宮崎純一博士への謝辞の表明を必要とする。
          提供依頼 手続きの詳細は、「提供申込みについて[link]」をご覧ください。
          提供依頼書 [Word]
          提供同意書 (MTA、非営利機関による非営利学術研究用)[Word]

          Catalog # Resource name Availability Shipping form Fee (non-profit org.)
          RDB01870 pCAZ 2 Under QC test. Please contact us. DNA solution Please contact us.

          check Please wait for results of QC test to be uploaded. This clone will be sequenced a portion for examination.
          Ordering Information [in Japanese] [in English]

          References and tips

          Electronic file

          Remarks, protocol and/or map (gif) RDB01870.gif

          Original reference

          original Yoshida, Y., Generation of fiber-mutant recombinant adenoviruses for gene therapy of malignant glioma. Hum. Gene Ther., 9, 2503-2515 (1998). PMID 9853517.

          Further references such as user reports and related articles (go to bottom)

          Featured content

          Featured content Control Vectors (English text)

          Sequence information

          check Please wait for results of QC test to be uploaded. This clone will be sequenced a portion for examination.


          References

          Original, user report and related articles

          original Yoshida, Y., Generation of fiber-mutant recombinant adenoviruses for gene therapy of malignant glioma. Hum. Gene Ther., 9, 2503-2515 (1998). PMID 9853517.
          user report Shimura, K., Prognostic significance of bone marrow FDG uptake in patients with gynecological cancer. Sci. Rep. 11 (1): 2257 (2021). PMID 33500424.
          user report Mabuchi, S., Pretreatment tumor-related leukocytosis misleads positron emission tomography-computed tomography during lymph node staging in gynecological malignancies. Nat. Commun. 11 (1): 1364 (2020). PMID 32170086.
          user report Komura, N., The Role of Myeloid-Derived Suppressor Cells in Increasing Cancer Stem-Like Cells and Promoting PD-L1 Expression in Epithelial Ovarian Cancer. Cancer Immunol. Immunother. 69 (12): 2477-2499 (2020). PMID 32561967.
          user report Kuroda, H., PM01183 inhibits myeloid-derived suppressor cells in vitro and in vivo. Immunotherapy 9 (10): 805-817 (2017). PMID 28877631.
          user report Smith, S.E., Maternal IL-6 can cause T cell-mediated juvenile alopecia by non-scarring follicular dystrophy in mice. Exp. Dermatol. 25 (3): 223-228 (2016). PMID 26660334.
          user report Yonenaga Y., The administration of naked plasmid DNA into the liver induces antitumor innate immunity in a murine liver metastasis model. J. Gene Med., 9, 299-307 (2007). PMID 17397091.
          user report Sakakima Y., Gene therapy for hepatocellular carcinoma using sonoporation enhanced by contrast agents Cancer Gene Ther., 12, 884-889 (2005). PMID 15891773.

          2022.02.09

          GNP_filter3_RDBDEP_html_220112.pl